AVITA Medical, Inc. Share Price Australian S.E.
Equities
AVH
AU000000AVH4
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.68 AUD | +2.29% | -3.60% | -37.53% |
17/04 | Wilsons Downgrades Avita Medical to Market-Weight From Overweight; Price Target is AU$3.03 | MT |
11/04 | BTIG Research Downgrades Avita Medical to Neutral From Buy | MT |
Sales 2024 * | 115M 75.53M 6.29B | Sales 2025 * | 164M 107M 8.93B | Capitalization | 337M 221M 18.38B |
---|---|---|---|---|---|
Net income 2024 * | -56M -36.67M -3.05B | Net income 2025 * | -17M -11.13M -927M | EV / Sales 2024 * | 2.75 x |
Net cash position 2024 * | 19.8M 12.96M 1.08B | Net cash position 2025 * | 1.85M 1.21M 101M | EV / Sales 2025 * | 2.05 x |
P/E ratio 2024 * |
-6.23
x | P/E ratio 2025 * |
-31.5
x | Employees | 207 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.34% |
Latest transcript on AVITA Medical, Inc.
1 day | +2.29% | ||
1 week | -3.60% | ||
Current month | -45.86% | ||
1 month | -44.17% | ||
3 months | -45.86% | ||
6 months | -8.84% | ||
Current year | -37.53% |
Date | Price | Change | Volume |
---|---|---|---|
29/24/29 | 2.68 | +2.29% | 16 399 |
26/24/26 | 2.62 | -5.42% | 614,020 |
24/24/24 | 2.77 | +2.97% | 281,858 |
23/24/23 | 2.69 | -3.24% | 545,617 |
22/24/22 | 2.78 | -0.71% | 567,535 |
Delayed Quote Australian S.E., April 29, 2024 at 06:00 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- RCEL Stock
- AVH Stock